Understanding Genes Behind Faster Aging: New Study Identifies 400 Genetic Factors Influencing Disparities

Researchers from the University of Colorado Boulder have spearheaded a study that illuminates the genetic underpinnings of aging. Published in Nature Genetics, the study showcases an international collaboration that has identified genes linked to accelerated aging in seven distinct categories, including cognitive decline, mobility issues, and social isolation.

Discoveries in the realm of genetics have brought to light the existence of over 400 genes connected to various types of unhealthy aging, offering insights into the disparities in how individuals age. This breakthrough provides a deeper understanding of why some people maintain their health and vigor into their late years, while others face significant health challenges earlier in life.

This research marks a significant advancement in the field, revealing that a wide array of genes is responsible for the various forms of aging-related decline. Isabelle Foote, the study's first author and a postdoctoral researcher at CU's Institute for Behavioral Genetics, emphasised the importance of understanding the biology behind accelerated aging to develop effective treatments. This study stands out as the largest of its kind to leverage genetics for this purpose.

The concept of frailty, defined as a multisystem physiological decline, is central to this study. Frailty affects over 40% of Americans over 65 and is traditionally assessed through a 30-point index that evaluates physical and cognitive health. This research supports the geroscience hypothesis, which posits that addressing aging itself could be key to treating the myriad chronic conditions that often accompany it.

However, this method does not differentiate between the various types of frailty, complicating the task of providing targeted care and understanding the specific causes of aging-related decline. Dr. Kenneth Rockwood, a co-author of the study from Dalhousie University in Nova Scotia, highlights the diversity in aging processes and the importance of identifying the genes involved.

In pursuit of answers, the research team conducted a genome-wide association study, analyzing the DNA and health information of hundreds of thousands of individuals from the UK Biobank and other databases. Their efforts led to the identification of 408 genes associated with different facets of unhealthy aging, a significant leap from the 37 previously known genes.

These genes are linked to various aging subtypes such as disability, poor cognition, and metabolic issues, among others. For instance, the SP1 gene, related to immune function and Alzheimer's disease, was strongly associated with cognitive decline, while the FTO gene, known for its connection to obesity, was linked to multiple aging-related conditions.

The study proposes expanding clinical assessments of frailty to encompass the six identified subtypes, enabling more personalised intervention strategies. Andrew Grotzinger, the study's senior author, sees this as a step towards treating the underlying biology of aging. The ultimate goal is to develop therapies that can slow down or even reverse the aging process.

While the concept of a single anti-aging pill remains unlikely, the research opens the door to the possibility of targeted treatments for specific age-related conditions. Grotzinger suggests that the future may hold a more nuanced approach to combating the effects of aging, with different treatments for various aspects of the aging process.